Mayne Pharma Group Ltd has released a press release.
Mayne Pharma capital management update
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Mayne Pharma completes sale of Metrics Contract Services
- Mayne Pharma - appointment of chief executive officer and Managing Director
- Mayne Pharma appoints new CEO
- Mayne Pharma Group - non-executive Director appointment and retirement
- 2022 Full Year Investor Presentation
Later from Mayne Pharma
- Dividend/Distribution - MYX
- Return of Capital - MYX
- AGM presentation and business and trading update
- MYX signs license agreement for womens health products
- MYX completes TherapeuticsMD product licensing transaction
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma